PMID: 6409272Jul 23, 1983Paper

Role of nifedipine in treatment of hypertension

British Medical Journal
M B MurphyC T Dollery

Abstract

The efficacy of nifedipine in the treatment of hypertension was assessed in 15 patients whose hypertension continued while being treated with atenolol 100 mg and bendrofluazide 5 mg daily. Nifedipine was added in doses of 10, 20, and 30 mg three times daily in a placebo controlled, double blind trial. One patient was withdrawn from the trial because of severe postural hypotension with the highest dose. Erect and supine blood pressure in the remaining 14 patients were significantly reduced by all doses of nifedipine. The drug was well tolerated but plasma potassium fell by 0.3 mmol(mEq)/1 during treatment (p less than 0.05). Nifedipine is thus effective in the treatment of hypertension but should probably be used in combination with a potassium sparing diuretic.

References

Sep 10, 1977·Lancet·H J DargieJ Daniel
Apr 3, 1969·The New England Journal of Medicine·S J Updike, A R Harrington
Jan 1, 1983·European Journal of Clinical Pharmacology·S Dean, M J Kendall
Dec 1, 1980·The American Journal of Cardiology·P D Henry
Feb 18, 1982·The American Journal of Cardiology·L B MitchellJ W Mason
Oct 1, 1982·British Journal of Clinical Pharmacology·S BayleyB F Robinson
Jan 1, 1982·European Journal of Clinical Pharmacology·M B MurphyC T Dollery
Nov 1, 1981·The Journal of Clinical Investigation·P D Henry, K I Bentley
Nov 1, 1980·British Journal of Clinical Pharmacology·B F RobinsonC R Kelsey
Feb 20, 1954·Journal of the American Medical Association·H M PERRY, H A SCHROEDER

❮ Previous
Next ❯

Citations

Jun 1, 1989·Cardiovascular Drugs and Therapy·L D RitchieM J Vandenburg
Jan 1, 1986·European Journal of Clinical Pharmacology·T HednerD Elmfeldt
Aug 1, 1990·Cardiovascular Drugs and Therapy·F Arrigo, F Consolo
Oct 1, 1987·American Heart Journal·B N Prichard, B Tomlinson
Aug 1, 1989·Pharmacology, Biochemistry, and Behavior·J S Turkkan, R D Hienz
Dec 24, 1997·British Journal of Pharmacology·M Taherzadeh, J B Warren
Oct 17, 1985·The New England Journal of Medicine·S H Snyder, I J Reynolds
Apr 1, 1990·British Journal of Clinical Pharmacology·D MacleanD G McDevitt
Dec 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·S CapewellA L Muir
Jan 1, 1989·Fundamental & Clinical Pharmacology·F Huguet
Oct 26, 1985·British Medical Journal·J Kenny
Feb 25, 1989·BMJ : British Medical Journal·M H Kaufman, R McNeil
Jan 1, 1986·European Journal of Applied Physiology and Occupational Physiology·H PetriM A van Baak
Jan 1, 1985·Clinical and Experimental Hypertension. Part A, Theory and Practice·L M WingA J Bune
Jan 1, 1986·Current Medical Research and Opinion·G R Nimmo, A A Lawson
Jan 1, 1987·Current Medical Research and Opinion·P SchnappJ Kahay
Jan 1, 1987·Current Medical Research and Opinion·J Duffy, G Macdonald
May 1, 1985·The American Journal of Cardiology·K TordjmanM Bursztyn
Oct 11, 1985·The American Journal of Medicine·R C DavidsonD K Stewart
Apr 1, 1988·British Journal of Clinical Pharmacology·D MacleanD G McDevitt
Apr 1, 1985·British Journal of Clinical Pharmacology·M D EneG Waddell
Jan 1, 1987·Journal of Clinical Pharmacology·A V ZezulkaD G Beevers
Oct 1, 1985·Annals of Emergency Medicine·K F Zangerle, R Wolford
Feb 1, 1986·American Heart Journal·A K Halperin, L X Cubeddu
Oct 24, 2017·Chemical Communications : Chem Comm·Qihui YuXuefeng Mei
Apr 1, 1986·Journal of Clinical and Hospital Pharmacy·J S GillD G Beevers
Jun 1, 1985·Journal of Clinical and Hospital Pharmacy·S A Smith, W A Littler
Dec 1, 1987·British Journal of Obstetrics and Gynaecology·G ConstantineD M Luesley
Jan 1, 1986·British Journal of Clinical Pharmacology·B N Prichard, C W Owens
Nov 19, 2019·Mini Reviews in Medicinal Chemistry·Abhinav Prasoon MishraAwani Kumar Rai
Dec 1, 1987·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·L A Cockhill, R A Remick
May 1, 1986·Drug Intelligence & Clinical Pharmacy·M Tishler, S Armon
Sep 24, 1998·The American Journal of Physiology·M TaherzadehJ B Warren
Oct 1, 1986·Scottish Medical Journal·J E RoulstonA L Muir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.